Vai a
  1. Homepage
  2. Ricerca e sperimen- tazioni
  3. Progetti di ricerca
Ricerca per malattia/gene

Ricerca per malattia/gene

*
(*) campo obbligatorio


 

Altre opzioni di ricerca

82 termini corrispondenti

Partnership : Accademici = Accademici 
, Industria = Industria 
, Investitori finanziari = Investitori finanziari

    • BELGIO
    • OOST-VLAANDEREN
    • GENT
    • Localisation, identification and functional characterisation of disease genes in retinitis pigmentosa.
    • Ghent University Hospital - UZGent
    • Center for Medical Genetics Ghent
    • Ulteriori dettagli
    • CANADA
    • Québec
    • MONTRÉAL
    • Accademici 
Industria 
Investitori finanziari
    • Finding genes and cures for childhood blindness due to Retinitis Pigmentosa and Leber Congenital Amaurosis
    • Montreal Children's hospital - Hôpital de Montréal pour enfants
    • Research Institute of McGill University Health Centre
    • Ulteriori dettagli
    • ESTONIA
    • Tartu
    • TARTU
    • AAVEYE: screening of samples from ophthalmological patients with retinitis pigmentosa and congenital Leber amaurosis (LCA and ARRP tests)
    • Asper Biotech Ltd.
    • Asper Biotech
    • Ulteriori dettagli
    • FINLANDIA
    • Finland
    • HELSINKI
    • Accademici 
Investitori finanziari
    • Inherited chorioretinal dystrophies of Finnish children with visual impairment born from 1990 through 2010 (LANVET2 Study)
    • Finnish Federation of the Visually Impaired
    • Ulteriori dettagli
    • FRANCIA
    • ALSACE
    • STRASBOURG
    • Retinis Pigmentosa: validation of the molecular diagnostic using next generation sequencing
    • CHU de Strasbourg - Hôpital Civil
    • Laboratoire de diagnostic génétique
    • Ulteriori dettagli
    • FRANCIA
    • ILE-DE-FRANCE
    • PARIS
    • Phenotype modifier factor research in women carrier of X-linked retinitis pigmentosa
    • CHU Paris - Hôpital Necker-Enfants Malades
    • Laboratoire de Génétique Moléculaire
    • Ulteriori dettagli
    • FRANCIA
    • ILE-DE-FRANCE
    • PARIS
    • Hereditary dystrophies of retina: physiopathologic and clinic research
    • Centre de Recherches Institut de la Vision
    • Institut de la Vision
    • Ulteriori dettagli
    • FRANCIA
    • ILE-DE-FRANCE
    • PARIS
    • Epidemiological study in hereditary dystrophies of retina
    • Centre de Recherches Institut de la Vision
    • Institut de la Vision
    • Ulteriori dettagli
    • FRANCIA
    • ILE-DE-FRANCE
    • PARIS
    • Hereditary dystrophies of retina: pharmacological research and new therapeutics development (cell and gene therapies)
    • Centre de Recherches Institut de la Vision
    • Institut de la Vision
    • Ulteriori dettagli
    • FRANCIA
    • ILE-DE-FRANCE
    • PARIS
    • Study of the main mechanisms involved in the death of retinal cells: study of neurotrophic factors protecting photoreceptors against degeneration and iron metabolism in retina
    • Centre de recherches des Cordeliers - CRC
    • Physiopathologie des maladies oculaires : innovations thérapeutiques
    • Ulteriori dettagli
    • FRANCIA
    • ILE-DE-FRANCE
    • PARIS
    • RHORCOD: comprehensive analysis of rod-cone photoreceptor degeneration associated with Rhodopsin gene mutations (coordination)
    • Centre hospitalier national d'ophtalmologie des Quinze-Vingts
    • Service d'ophtalmologie IV
    • Ulteriori dettagli
    • FRANCIA
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Visual cycle regulation and RPE65 protein's partner
    • CHRU de Montpellier - Hôpital Saint-Eloi
    • Equipe Génétique et thérapie des cécités rétiniennes et du nerf optique
    • Ulteriori dettagli
    • FRANCIA
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Genetics of autosomal recessive retinitis pigmentosa and of macular dystrophies
    • CHRU de Montpellier - Hôpital Saint-Eloi
    • Equipe Génétique et thérapie des cécités rétiniennes et du nerf optique
    • Ulteriori dettagli
    • FRANCIA
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Genetics of retinitis pigmentosa
    • CHRU de Montpellier - Hôpital Saint-Eloi
    • Equipe Génétique et thérapie des cécités rétiniennes et du nerf optique
    • Ulteriori dettagli
    • FRANCIA
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Dominant autosomic retinitis pigmentosa: prevalence of known genes and identification of new ones
    • CHRU de Montpellier - Hôpital Saint-Eloi
    • Equipe Génétique et thérapie des cécités rétiniennes et du nerf optique
    • Ulteriori dettagli
    • FRANCIA
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Gene therapy of retinal dystrophy on human models: differentiation of patients iPS cells to retinal cells
    • CHRU de Montpellier - Hôpital Saint-Eloi
    • Equipe Génétique et thérapie des cécités rétiniennes et du nerf optique
    • Ulteriori dettagli
    • FRANCIA
    • PAYS DE LA LOIRE
    • NANTES
    • RPE65 gene mutation search in Leber amaurosis and retinitis pigmentosa patients
    • CHU de Nantes
    • Délégation Régionale à la Recherche Clinique
    • Ulteriori dettagli
    • FRANCIA
    • PAYS DE LA LOIRE
    • NANTES
    • Evaluation of the immune response in Briards dogs RPE65 -/- treated with gene therapy
    • CHU de Nantes - Hôtel Dieu
    • Vecteurs viraux et transfert de genes in vivo
    • Ulteriori dettagli
    • FRANCIA
    • PAYS DE LA LOIRE
    • NANTES
    • RPE65 gene mutation search in Leber amaurosis and retinitis pigmentosa patients
    • CHU de Nantes - Hôtel Dieu
    • Service d'ophtalmologie
    • Ulteriori dettagli
    • FRANCIA
    • RHONE-ALPES
    • LYON
    • LipidinRetina: Dysregulation of lipid metabolism on photoreceptor function and viability : The role of FATP genes in Drosophila and mice models
    • ENS - Ecole normale supérieure de Lyon
    • Laboratoire de Biologie Moléculaire de la Cellule
    • Ulteriori dettagli
    • GERMANIA
    • Baden-Württemberg
    • FREIBURG
    • SYSCILIA - Component 3 - "Assessing and manipulating the variables of ciliary systems" (WP5)
    • Universitätsklinikum Freiburg
    • The Walz lab - Hereditary Kidney Diseases - Molecular Biology
    • Ulteriori dettagli
    • GERMANIA
    • Baden-Württemberg
    • TÜBINGEN
    • HOPE2: Hereditary Retinal Disorders - From patients towards therapies: modifying factors and functional assessment of gene variants (subproject 4)
    • Universitätsklinikum Tübingen
    • Molekulargenetisches Labor
    • Ulteriori dettagli
    • GERMANIA
    • Baden-Württemberg
    • TÜBINGEN
    • Phenotype-genotype correlation in hereditary degeneration of the retina and the optic nerve (extended function analysis and differentiation, neuro-ophthalmology, mouse models)
    • Universitätsklinikum Tübingen
    • Forschungsinstitut für Augenheilkunde
    • Ulteriori dettagli
    • GERMANIA
    • Baden-Württemberg
    • TÜBINGEN
    • CRUMBS IN SIGHT: restoring Mueller glia cell photoreceptor interactions with Crumbs (partner)
    • Universitätsklinikum Tübingen
    • Forschungsinstitut für Augenheilkunde
    • Ulteriori dettagli
    • GERMANIA
    • Baden-Württemberg
    • TÜBINGEN
    • HOPE2: Hereditary Retinal Disorders - From Patients Towards Therapies to each project: Translation of novel diagnostics procedures and evaluation of experimental therapies in hereditary retinal disorders (subproject 2)
    • Universitätsklinikum Tübingen
    • Forschungsinstitut für Augenheilkunde
    • Ulteriori dettagli
    • GERMANIA
    • Baden-Württemberg
    • TÜBINGEN
    • HOPE2: Hereditary Retinal Disorders - From patients towards therapies : validation and application of retina-derived neuroprotective factors to the dystrophic retina (subproject 5 )
    • Universitätsklinikum Tübingen
    • Forschungsinstitut für Augenheilkunde
    • Ulteriori dettagli
    • GERMANIA
    • Baden-Württemberg
    • TÜBINGEN
    • RHORCOD: comprehensive analysis of rod-cone photoreceptor degeneration associated with Rhodopsin gene mutations (partner)
    • Universitätsklinikum Tübingen
    • Forschungsinstitut für Augenheilkunde
    • Ulteriori dettagli
    • GERMANIA
    • Baden-Württemberg
    • TÜBINGEN
    • SYSCILIA - Component 1 -"Defining the elements and variables of ciliary systems" (WP1 and WP2)
    • Universitätsklinikum Tübingen
    • Forschungsinstitut für Augenheilkunde
    • Ulteriori dettagli
    • GERMANIA
    • Baden-Württemberg
    • ULM
    • Excitation-contraction coupling in health and disease: Ion channel diseases - diagnosis, pathogenesis and therapy
    • Universität Ulm
    • Institut für Angewandte Physiologie
    • Ulteriori dettagli
    • GERMANIA
    • Bayern
    • ALZENAU
    • HOPE2: Hereditary Retinal Disorders - From patients towards therapies : development of suitable CellBead® systems for preclinical studies and human use including testing of existing CellBeads® for human use in animal studies (subproject 6)
    • Cellmed AG
    • Ulteriori dettagli
    • GERMANIA
    • Bayern
    • REGENSBURG
    • HOPE2: Hereditary Retinal Disorders - From Patients Towards Therapies: Integrated diagnostics in hereditary retinal disorders (subproject 3)
    • Universitätsklinikum Regensburg
    • Zentrum und Institut für Humangenetik Regensburg
    • Ulteriori dettagli
    • GERMANIA
    • Bayern
    • REGENSBURG
    • Functional analysis of FAM161A proteine and investigation of FAM161A associated retinal degeneration
    • Universitätsklinikum Regensburg
    • Zentrum und Institut für Humangenetik Regensburg
    • Ulteriori dettagli
    • GERMANIA
    • Berlin
    • BERLIN
    • Stem cell based therapy in a mouse model with rhodopsin associated retinal degeneration
    • Augenarzt-Praxis in Berlin-Mitte
    • Ulteriori dettagli
    • GERMANIA
    • Berlin
    • BERLIN
    • Phenotyping of mouse lines with retinal functional impairment and retinal degeneration
    • Augenarzt-Praxis in Berlin-Mitte
    • Ulteriori dettagli
    • GERMANIA
    • Hessen
    • GIEßEN
    • Genotype phenotype correlation of hereditary eye diseases
    • Universitätsklinikum Gießen und Marburg GmbH, Standort Gießen
    • Klinik und Poliklinik für Augenheilkunde
    • Ulteriori dettagli
    • GERMANIA
    • Hessen
    • GIEßEN
    • Diagnosis and therapy of hereditary retinal diseases
    • Universitätsklinikum Gießen und Marburg GmbH, Standort Gießen
    • Klinik und Poliklinik für Augenheilkunde
    • Ulteriori dettagli
    • GERMANIA
    • Nordrhein-Westfalen
    • BONN
    • Two photon excited fluorescence imaging using a femtosecond Ti:sapphire
    • Universitätsklinikum Bonn
    • Universitäts-Augenklinik Bonn
    • Ulteriori dettagli
    • GERMANIA
    • Nordrhein-Westfalen
    • KÖLN
    • Functional analysis of FAM161A proteine and investigation of FAM161A associated retinal degeneration
    • Universitätsklinikum Köln
    • Zentrum für Augenheilkunde
    • Ulteriori dettagli
    • GERMANIA
    • Nordrhein-Westfalen
    • SIEGBURG
    • Genotype-phenotype correlations and long-term evaluation in inherited retinal dystrophies and optic neuropathies
    • Augenzentrum Siegburg
    • AugenZentrum Siegburg Professor Dr. med. Ulrich Kellner
    • Ulteriori dettagli
    • GERMANIA
    • Nordrhein-Westfalen
    • SIEGBURG
    • Optical coherence tomography (OCT), fundus autofluorescence (FAF) and near-infrared autofluorescence (NIA) imaging for early detection and differentiation of retinal dystrophies
    • Augenzentrum Siegburg
    • AugenZentrum Siegburg Professor Dr. med. Ulrich Kellner
    • Ulteriori dettagli
    • GERMANIA
    • Nordrhein-Westfalen
    • SIEGBURG
    • Web-based interactive information for patients with inherited retinal and visual pathway disorders
    • Augenzentrum Siegburg
    • AugenZentrum Siegburg Professor Dr. med. Ulrich Kellner
    • Ulteriori dettagli
    • GERMANIA
    • Rheinland-Pfalz
    • INGELHEIM AM RHEIN
    • Identification and functional characterisation of new mutations in the known genes for hereditary non-syndromic hearing loss, Retinitis pigmentosa and Usher syndrome
    • Bioscientia Institut für Medizinische Diagnostik GmbH
    • Labor Ingelheim mit Zentrum für Humangenetik
    • Ulteriori dettagli
    • GERMANIA
    • Sachsen
    • DRESDEN
    • CRUMBS IN SIGHT: restoring Mueller glia cell photoreceptor interactions with Crumbs (partner)
    • Max-Planck-Institut für molekulare Zellbiologie und Genetik
    • Forschungsgruppe Elisabeth Knust
    • Ulteriori dettagli
    • IRLANDA
    • Leinster
    • DUBLIN
    • Exploration of the use of in vitro expanded progenitor / stem cells for the treatment of retinal degenerations in mouse models of retinitis pigmentosa.
    • Trinity College Dublin
    • Ocular Genetics Unit
    • Ulteriori dettagli
    • IRLANDA
    • Leinster
    • DUBLIN
    • Human Molecular/Medical Genetics with special interest in hereditary neurodegenerative diseases of the retina
    • Trinity College Dublin
    • Ocular Genetics Unit
    • Ulteriori dettagli
    • IRLANDA
    • Leinster
    • DUBLIN
    • Regulatory role of miRNAs in retinitis pigmentosa models
    • Trinity College Dublin
    • Ocular Genetics Unit
    • Ulteriori dettagli
    • ITALIA
    • CAMPANIA
    • NAPOLI
    • AAVEYE: strategie di terapia genica per le malattie ereditarie gravi dei fotorecettori (Coordinamento)
    • TIGEM - Telethon Institute of Genetics and Medicine
    • Laboratorio di Ricerca
    • Ulteriori dettagli
    • ITALIA
    • CAMPANIA
    • NAPOLI
    • AAVEYE: optimization of AAV-mediated photoreceptor gene transfer for gene therapy of PDE6B and AIPL1 deficiencies (WP1)
    • TIGEM - Telethon Institute of Genetics and Medicine
    • Laboratorio di Ricerca
    • Ulteriori dettagli
    • ITALIA
    • CAMPANIA
    • NAPOLI
    • Identificazione di network genici regolati da microRNA nella retina umana
    • TIGEM - Telethon Institute of Genetics and Medicine
    • Laboratorio di Ricerca
    • Ulteriori dettagli
    • ITALIA
    • EMILIA ROMAGNA
    • MODENA
    • Studi integrati in silico, in vitro ed in vivo verso la progettazione di potenziali agenti terapeutici per la Retinite Pigmentosa
    • Università degli Studi di Modena e Reggio Emilia
    • Laboratorio Eye Diseases
    • Ulteriori dettagli
    • ITALIA
    • LAZIO
    • ROMA
    • AAVEYE: optimization of AAV-mediated photoreceptor gene transfer for gene therapy of PDE6B and AIPL1 deficiencies (WP1)
    • Fondazione Telethon
    • Ulteriori dettagli
    • ITALIA
    • LIGURIA
    • GENOVA
    • Sviluppo di interfacce biorganiche fotovoltaiche e loro applicazione come protesi retiniche per la cura della retinite pigmentosa
    • IRCCS Azienda Ospedaliera Universitaria S. Martino
    • Dipartimento di Medicina Sperimentale
    • Ulteriori dettagli
    • ITALIA
    • LOMBARDIA
    • MILANO
    • Sviluppo di interfacce bio-organiche fotovoltaiche e loro applicazione come protesi retiniche per la cura della retinite pigmentosa
    • Center for Nano Science and Technology
    • Center for Nanoscience and Technology
    • Ulteriori dettagli
    • ITALIA
    • TOSCANA
    • PISA
    • Degenerazione dei neuroni della retina interna nella retinite pigmentosa
    • Consiglio Nazionale delle Ricerche CNR
    • Area della Ricerca
    • Ulteriori dettagli
    • ITALIA
    • TOSCANA
    • PISA
    • Cellular pathways of apoptosis in degenerating photoreceptors (a multidisciplinary approach aimed at understanding the role of the ceramide sphingolipid pathway in the degeneration process of photoreceptors in mouse models of retinitis pigmentosa)
    • Consiglio Nazionale delle Ricerche CNR
    • Area della Ricerca
    • Ulteriori dettagli
    • ITALIA
    • TOSCANA
    • PISA
    • Istopatologia della retina in modelli animali di Retinite Pigmentosa. Approcci terapeutici per i fotorecettori.
    • Consiglio Nazionale delle Ricerche CNR
    • Area della Ricerca
    • Ulteriori dettagli
    • ITALIA
    • TOSCANA
    • PISA
    • Come trasformare cellule staminali embrionali in cellule retiniche: ruolo di geni specifici dell'occhio
    • Università degli Studi di Pisa
    • Dipartimento di Biologia
    • Ulteriori dettagli
    • PAESI BASSI
    • Gelderland
    • NIJMEGEN
    • Identification of the genetic causes of inherited retinal dystrophies
    • Radboudumc - Radboud universitair medisch centrum
    • Afdeling Genetica
    • Ulteriori dettagli
    • PAESI BASSI
    • Gelderland
    • NIJMEGEN
    • Identification of the genetic causes of inherited retinal dystrophies
    • Radboudumc - Radboud universitair medisch centrum
    • Afdeling Oogheelkunde
    • Ulteriori dettagli
    • PAESI BASSI
    • Noord-Holland
    • AMSTERDAM
    • CRUMBS IN SIGHT: restoring Mueller glia cell photoreceptor interactions with Crumbs (coordination)
    • NIN - Netherlands Institute for Neuroscience
    • Department of Neuromedical Genetics
    • Ulteriori dettagli
    • REGNO UNITO; GRAN BRETAGNA
    • Cambridgeshire
    • CAMBRIDGE
    • NIHR BioResource - Rare Disease: SPEED - Specialist Pathology: Evaluating Exomes in Diagnostics
    • Wellcome Trust/MRC Building
    • Cambridge Institute for Medical Research
    • Ulteriori dettagli
    • REGNO UNITO; GRAN BRETAGNA
    • Greater London
    • LONDON
    • Investigation of the molecular mechanisms between mutations in TOPORS gene and their relation with retinitis pigmentosa
    • UCL Institute of Ophthalmology
    • UCL Neuroscience
    • Ulteriori dettagli
    • REGNO UNITO; GRAN BRETAGNA
    • Greater London
    • LONDON
    • AAVEYE: gene replacement therapy in Pde6B and Aipl1 murine mutants (WP2)
    • UCL Institute of Ophthalmology
    • Molecular Therapy
    • Ulteriori dettagli
    • REGNO UNITO; GRAN BRETAGNA
    • Greater London
    • LONDON
    • AAVEYE: molecular and clinical characterization of Retinitis pigmentosa and Leber congenital amaurosis patients with PDE6B and AIPL1 mutations (WP4)
    • UCL Institute of Ophthalmology
    • Molecular Therapy
    • Ulteriori dettagli
    • REGNO UNITO; GRAN BRETAGNA
    • West Midlands
    • BIRMINGHAM
    • NIPSIGEN - Clinical translation of non-invasive prenatal diagnosis (NIPD) for single gene disorders (Health Innovation Challenge Fund)
    • Birmingham Women's NHS Foundation Trust
    • Regional Genetics Unit
    • Ulteriori dettagli
    • SPAGNA
    • Andalucía
    • SEVILLA
    • Identification of new genes responsible for inherited retinal dystrophies by Next-Generation Sequencing technology and determination of the pathogenic mechanisms associated
    • Hospital Universitario Virgen del Rocío
    • Unidad de Gestión Clínica de Genética, Reproducción y Medicina Fetal
    • Ulteriori dettagli
    • SPAGNA
    • Castilla - León
    • SALAMANCA
    • Analysis of the contribution of protein CRB2 to the establishment and maintenance of adherens junctions of the pigment epithelium and its relationship with retinitis pigmentosa and age-related macular degeneration
    • Instituto de Neurociencias de Castilla y León
    • Departamento de Biología Celular y Patología (USAL)
    • Ulteriori dettagli
    • SPAGNA
    • Cataluña
    • BARCELONA
    • Design of a genetic diagnostic chip for retinal dystrophies
    • Universitat de Barcelona. Facultat de Biologia
    • Departamento de Genética
    • Ulteriori dettagli
    • SPAGNA
    • Cataluña
    • TERRASSA
    • Folding and function alterations of cellular factor mutated opsins such as a new therapeutic approach for retinal degenerative diseases: retinitis pigmentosa and cone rod dystrophy
    • Universitat Politècnica de Catalunya - Campus de Terrassa
    • Grupo de Biotecnología Molecular e Industrial
    • Ulteriori dettagli
    • SPAGNA
    • Comunidad Valenciana
    • VALENCIA
    • Alterations of the intracellular protein degradation mechanisms in Lafora disease, X-linked cerebral adrenoleukodystrophy and retinitis pigmentosa
    • Centro de Investigación Príncipe Felipe (CIPF)
    • Laboratorio de Biología Celular (CIPF)
    • Ulteriori dettagli
    • SPAGNA
    • Madrid
    • MADRID
    • Characterization of programmed cell death during neurogenesis and in retinal degeneration models: study of the possible therapeutical application of proinsulin in retinitis pigmentosa
    • Centro de Investigaciones Biológicas (CSIC)
    • Departamento de Medicina Celular y Molecular
    • Ulteriori dettagli
    • SPAGNA
    • Madrid
    • MADRID
    • Study of autosomal recessive retinal dystrophies and others: a) Clinical and molecular characterization by new methodological approaches; b) Identification of new candidate regions
    • Fundación Jiménez Díaz
    • Servicio de Genética Médica
    • Ulteriori dettagli
    • SPAGNA
    • Madrid
    • MADRID
    • New genes and mechanisms in Retinal dystrophies. Application of whole-exome sequencing and systems biology, functional studies in animal models and clinical characterization
    • Fundación Jiménez Díaz
    • Servicio de Genética Médica
    • Ulteriori dettagli
    • SVEZIA
    • Skane
    • LUND
    • Retinal transplantation: strategies for clinical therapy of Retinitis pigmentosa
    • Lund University
    • Division of Ophthalmology
    • Ulteriori dettagli
    • SVEZIA
    • Skane
    • LUND
    • Inherited retinal degeneration: Mechanisms and experimental therapy
    • Lund University
    • Division of Ophthalmology
    • Ulteriori dettagli
    • SVEZIA
    • Stockholms läns landsting
    • STOCKHOLM
    • Genetic and molecular mechanisms in familial visual impairment
    • Karolinska Institutet
    • Department of molecular medicine and surgery
    • Ulteriori dettagli
    • SVIZZERA
    • Suisse Alémanique
    • SCHLIEREN
    • Pathological mechanisms of mutations in the human RP3/RPGR gene (Retinitis Pigmentosa 3)
    • Universität Zürich
    • Institüt für Medizinische Molekulargenetik
    • Ulteriori dettagli
    • SVIZZERA
    • Suisse Alémanique
    • SCHLIEREN
    • Molecular and functional analyses of two X-linked forms of Retinitis Pigmentosa (RP2 and RP3)
    • Universität Zürich
    • Institüt für Medizinische Molekulargenetik
    • Ulteriori dettagli
    • SVIZZERA
    • Suisse Alémanique
    • SCHLIEREN
    • The genetic and molecular basis of retinal dystrophies
    • Universität Zürich
    • Institüt für Medizinische Molekulargenetik
    • Ulteriori dettagli
    • SVIZZERA
    • Suisse Italienne
    • BELLINZONA
    • Investigating cellular mechanisms regulating protein folding and quality control to intervene in conformational diseases
    • Istituto di Ricerca in Biomedicina
    • Protein Folding and Quality Control - Institute for Research in Biomedicine
    • Ulteriori dettagli
    • SVIZZERA
    • Suisse Romande
    • LAUSANNE
    • Fighting blindness by controlling retinal stem cell renewal and differentiation
    • Hôpital Ophtalmique Jules Gonin - Université de Lausanne
    • Unit of Gene Therapy & Stem Cell Biology - Hôpital Ophtalmique Jules Gonin
    • Ulteriori dettagli
    • SVIZZERA
    • Suisse Romande
    • LAUSANNE
    • AAVEYE: combined therapies to restore vision in Pde6B and Aipl1 murine mutants (WP3)
    • Hôpital Ophtalmique Jules Gonin - Université de Lausanne
    • Unit of Gene Therapy & Stem Cell Biology - Hôpital Ophtalmique Jules Gonin
    • Ulteriori dettagli